NovoCure Stock: Buy Rating As Pipeline Gains Drive Renewed Momentum (NASDAQ:NVCR)

NovoCure Limited (NASDAQ: NVCR ) stock is having an exciting month as it is now in double-digit wins, although still trading near its 52-week lows. The company's Q3 financial results update has been scheduled forGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gamu has a proven track ...